Australian women's prediagnostic values and influencing sociodemographic variables relating to treatment choices for early breast cancer treatment
Budden, Lea M., Hayes, Barbara A., Pierce, Penny F., and Buettner, Petra G. (2007) Australian women's prediagnostic values and influencing sociodemographic variables relating to treatment choices for early breast cancer treatment. Australian Journal of Cancer Nursing, 8 (1). pp. 9-20.
PDF (Published Version)
Women are often asked by their doctors to choose their preferred treatment for early breast cancer. Evidence shows that many women are distressed and confused about how to make this treatment decision and frequently seek help from nurses. Very little is known about women's value-centred decision-making in relation to selecting treatment for breast cancer and for nurses it is difficult to know how to assist these women with this process. In this study, 377 women participated prior to undergoing routine mammography screening and the data were collected using the Pre-Decision Portfolio Questionnaire (PDPQ) by Pierce 1. The partipants identified that expected treatment outcomes were the most important factor in choosing early breast cancer treatment. The majority reported that it was very important that a treatment would reduce the chances the cancer would return (95.6%), increase the length of their life (82.1%) and lead them to being healthy (80.4%). In addition, the participants indicated that it was important, or very important, that the emotional consequences of the treatment did "not make you depressed" (88.6%) or "sad" (90.4%) and should "keep you from worrying" (97%) and "give you peace of mind" (98.6%). Other factors, such as treatment's side effects, were identified as less important. Age, employment, education and having a family history of breast cancer were found to be significant influencing variables on the values of the participants. It was concluded that assessing and understanding the treatment values of women can help nurses focus on areas of importance to the woman and lead to informed decision-making when they are choosing treatment for early breast cancer.
|Item Type:||Article (Refereed Research - C1)|
|Date Deposited:||09 Apr 2009 05:12|
Last 12 Months: 8